On December 7, 2022, Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC issued a statement recommending stockholders vote on Camac Partners? proxy card to remove Pasithea Therapeutics Corp.?s Board of Directors at the upcoming special meeting of stockholders scheduled for December 9th, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.92 USD | -.--% | -4.42% | -6.49% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.49% | 7.21M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Concord IP2 Recommends Stockholders to Vote for Boardroom Change at Pasithea Therapeutics